Sankyo Articles
Lilly and Daiichi present heart-attack study
17 November 2008
Japan stock market week to Nov 3, 2008
10 November 2008
Daiichi acquires Merck Serono Turkish staff
10 November 2008
FDA delays NDA reviews despite budget rise
3 November 2008
Japan stock market week to Oct 27, 2008
3 November 2008
Daiichi Sankyo's tender offer for Ranbaxy successful
27 October 2008
Lilly/Daiichi reassure investors on prasugrel
27 October 2008
Japan stock market week to Oct 13, 2008
20 October 2008
Daiichi Sankyo plans to become a leader in antithrombotics with prasugrel and DU-176b
20 October 2008
Japan stock market week to Sept 29, 2008
6 October 2008
Japan stock market week to Sept 22, 2008
29 September 2008
Ranbaxy responds to FDA allegations
29 September 2008
US FTC challenges Fresenius deal
22 September 2008
US FTC challenges Fresenius deal
22 September 2008
Japan stock market week to Sept 8, 2008
15 September 2008
EU Commission clears Daiichi Sankyo's purchase of Ranbaxy
15 September 2008
Japan stock market week to Sept 1, 2008
8 September 2008
Daiichi Sankyo reports on Factor Xa inhibitor
8 September 2008
UPDATE: Prasugrel better than Plavix in preventing ACS in diabetics
8 September 2008
Recurrent events 35% less likely with prasugrel than Plavix
1 September 2008
Biota's novel antiviral "indistinguishable" from oseltamivir
11 August 2008
Ranbaxy's 2nd-qtr 2008 sales rise 13% to $432M
11 August 2008
Japan stock market week to August 4, 2008
11 August 2008
Teva targets Japanese market, says CEO
4 August 2008
Japan stock market week to July 28, 2008
4 August 2008
Merck KGaA ceases promotion of off-patent drugs
21 July 2008
Japan stock market week to July 14, 2008
21 July 2008
Ranbaxy denies it forged drug data
21 July 2008
Japan stock market week to June 30, 2008
7 July 2008
Three-month delay for US prasugrel NDA
30 June 2008
Japan stock market week to June 23, 2008
30 June 2008
Pfizer to settle patent disputes with Ranbaxy
23 June 2008
Benicar effective in reversing artery narrowing
23 June 2008
Pfizer may counter Daiichi Sankyo bid for Ranbaxy
23 June 2008
Daiichi Sankyo in deal to control Ranbaxy
16 June 2008
Japan stock market week to June 9, 2008
16 June 2008
Mylan sued by Daiichi Sankyo over Azor patent
9 June 2008
JPMA elects new officers
2 June 2008
Japan stock market week to May 26, 2008
2 June 2008
German biotech buy: start of a new tend?
2 June 2008
Daiichi Sankyo takes over U3 Pharma
26 May 2008
Japan stock market week to May 19, 2008
26 May 2008
Forest takes $44M hit on ending Azor deal
19 May 2008
Daiichi Sankyo sets up unit in Turkey
19 May 2008
GSK drops Japanese partner for Zantac
28 April 2008
Japan stock market week to April 7, 2008
14 April 2008
Japan stock market week to March 31, 2008
7 April 2008
Daiichi Sankyo extends MorphoSys accord
31 March 2008
Japan stock market week to March 17, 2008
24 March 2008
Daiichi Sankyo to strengthen European presence
17 March 2008
Japan stock market week to Feb 25, 2008
3 March 2008
FDA awards priority review for prasugrel
3 March 2008
FDA accepts NDA for Kissei's BPH drug
25 February 2008
Tokyo stocks in the week to February 18, 2008
25 February 2008
Japanese pharma companies are steadily penetrating global markets
25 February 2008
Fujifilm buying Toyama for up to $1.46B
25 February 2008
Japan stock market week to February 4 , 2008
14 February 2008
US physician survey finds big differences in Rx patterns between cardiologists and PCPs
4 February 2008
Japan stock market week to Jan 28, 2008
4 February 2008
Japan stock market week to Jan 21, 2008
28 January 2008
Lexapro and Namenda help Forest's income for fiscal 3rd-qtr soar 21%, beating estimates
21 January 2008
Daiichi Sankyo and Eli Lilly submit NDA to US FDA for prasugrel; to be sold as Effient
14 January 2008
FDA clears orphan drug Kuvan for PKU
14 January 2008
Christian Deleuze and Michael Seeley join LEEM
14 January 2008
Tokyo stocks to January 7, 2008
14 January 2008
Olmetec first ARB to show sclerotic regress
17 December 2007
Japan stock market week to Dec 10, 2007
17 December 2007
Daiichi Sankyo to ramp up US operations
3 December 2007
Japan stock market week to Nov 26, 2007
3 December 2007
Biota's flu drug enters Ph II trials
26 November 2007
Lilly/Daiichi Sankyo's prasugrel cuts CV AEs 19% vs Plavix, but side effects raise doubts
21 November 2007
Japan stock market week to Nov 12, 2007
19 November 2007
Japan stock market week to November 5, 2007
12 November 2007
Japan stock market week to Oct 29, 2007
5 November 2007
Two prasugrel trials suspended on dosage issues
29 October 2007
Forest's EPS drops 5% on Microbia charge
29 October 2007
Daiichi Sankyo and Forest finalize Azor co-promotion deal
22 October 2007
Statins provide benefits after use stopped
22 October 2007
Tokyo stocks to October 8, 2007
15 October 2007
Daiichi Sankyo files CS-8663 in Europe
8 October 2007
YM Biosci's fiscal 2007 income triples to $7.6M
8 October 2007
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
